Comparative efficacy of different treatment regimens against bovine mastitis caused by Staphylococcus aureus

Comparative efficacy of different treatment regimens against bovine mastitis caused by Staphylococcus aureus

Bovine mastitis is an endemic disease among dairy cattle all over the world and antimicrobial therapy is one of the prime therapeutic and prophylactic tool against mastitis. In the present scenario, the efficacy of antimicrobial chemotherapy is being threatened by the rising tide of antimicrobial re...

Full description

Bibliographic Details
Main Authors:	Krupa Rose Jose, K. Vijayakumar, K. Justin Davis, V. H. Shyma, R. Ambily
Format:	Article
Language:	English
Published:	Director of Academics and Research, Kerala Veterinary and Animal Sciences University 2021-01-01
Series:	Journal of Veterinary and Animal Sciences
Subjects:	mastitis ceftriaxone ceftriaxone sulbactam sulphadiazine trimethoprim clinicotherapeutic efficacy
Online Access:	https://www.jvas.in/public_html/upload/article_file/article_file_qutjx9.pdf?t=qutjx9

Similar Items

Evaluation of ceftriaxone-sulbactam-disodium edetate adjuvant combination against multi-drug resistant Gram-negative organisms
by: Shilpi Gupta, et al.
Published: (2020-12-01)

Current approaches to the treatment of complicated pyelonephritis: protected cephalosporin use, including the combination of ceftriaxone/sulbactam
by: Ya.A. Dombrovskyi, et al.
Published: (2015-02-01)

Current approaches to the treatment of complicated pyelonephritis: protected cephalosporin use, including the combination of ceftriaxone/sulbactam
by: Ya.A. Dombrovskyi, et al.
Published: (2015-02-01)

MILK LEVEL OF CEFTIZOXIME FOLLOWING SINGLE INTRAMUSCULAR DOSING OF CEFTRIAXONE WITHOUT AND WITH ORAL ADMINISTRATION OF FIBROSIN® AND ITS EFFECT ON MILK ENZYME ACTIVITY IN GOAT
by: T. K. Sar, et al.
Published: (2014-12-01)

Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
by: Benjamin H. Gern, et al.
Published: (2018-02-01)

Kidney Stones and Ceftriaxone
by: Murat Dursun, et al.
Published: (2015-01-01)

Ceftriaxone‐associated pseudolithiasis
by: Masaru Kurihara, et al.
Published: (2021-09-01)

The contribution of nano‐based strategies in overcoming ceftriaxone resistance: a literature review
by: Ashagrachew Tewabe, et al.
Published: (2021-08-01)

Screening of five drugs for efficacy against Babesia felis in experimentally infected cats : research communication
by: B.L. Penzhorn, et al.
Published: (2000-07-01)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
by: Brigitte Lefebvre, et al.
Published: (2018-02-01)

Appropriate Use of Ceftriaxone in Sub-Saharan Africa: A Systematic Review
by: Meresa Bishaw B, et al.
Published: (2021-08-01)

Ceftriaxone-associated pseudolithiasis in hemodialysis patients: a case series study
by: Yuko Oyama, et al.
Published: (2021-02-01)

Gatifloxacin in the treatment of community-acquired pneumonias: a comparative trial of ceftriaxone, with or without macrolides, in hospitalized adult patients with mild to moderately severe pneumonia
by: J.S. Mendonça, et al.

The Dark Purple Side of Ceftriaxone: A Case Report on Leucocytoclastic Vasculitis
by: Elia Rigamonti, et al.
Published: (2020-03-01)

7-{[2-(4-Hydroxyphenyl)methylidene]amino}-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
by: Ghulam Fareed, et al.
Published: (2012-05-01)

PHARMACOKINETICS OF CEFTRIAXONE FOLLOWING INTRAMUSCULAR ADMINISTRATION IN LOCAL PIG OF MIZORUM, INDIA
by: Lalrin Puia, et al.
Published: (2016-12-01)

Comparison of prevalence of hypercalciuria after intravenous injection of ceftriaxone versus ampicillin and cefotaxime in children with febrile infection
by: Maryam Esteghamati, et al.
Published: (2019-03-01)

Water transport through rat colonic epithelium during ceftriaxone therapy
by: T. Dovbynchuk, et al.
Published: (2016-07-01)

Published: (1998-12-01)

Ceftriaxone treatment of syphilis
by: Georgiy L. Katunin, et al.
Published: (2021-04-01)

Ceftriaxone Induced Unilateral Facial Angioedema
by: Recep Alanli
Published: (2019-05-01)

Ceftriaxone Drug Utilization Evaluation (DUE) at Prince Abdulaziz Bin Moussae’ed Hospital, Arar, Kingdom of Saudi Arabia
by: Muhammad Jan Shamsur Rehman, et al.
Published: (2019-12-01)

Campylobacter fetus bacteremia and meningitis in an acute lymphoblastic leukemia patient undergoing maintenance therapy: a case report
by: Ryo Nakatani, et al.
Published: (2021-07-01)

Clinical Pharmacology of Ceftriaxone in Neonates and Infants: Effects and Pharmacokinetics
by: Gian Maria Pacifici, et al.
Published: (2017-09-01)

Toxic epidermal necrolysis secondary to ceftriaxone use: A case report
by: Mustafa İçer, et al.
Published: (2015-12-01)

Spectrophotometric Determination of Ceftriaxone Using 4-Dimethylaminobenzaldehyde
by: F.M.A. Rind*1, , , , , , and, et al.
Published: (2008-06-01)

Ceftriaxone-associated nephrolithiasis and gallstone in adults
by: Azarkar G, et al.
Published: (2018-12-01)

Fecal short-chain fatty acids at different time points after ceftriaxone administration in rats
by: Yu. V. Holota, et al.
Published: (2017-02-01)

Intravenous Ceftriaxone Versus Multiple Dosing Regimes of Intravenous Anti-Staphylococcal Antibiotics for Methicillin-Susceptible <i>Staphylococcus aureus</i> (MSSA): A Systematic Review
by: Musaiwale M. Kamfose, et al.
Published: (2020-01-01)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
by: Alan R. Katz
Published: (2018-03-01)

Radiolabeling of Ceftriaxone with 99mTc as a Targeting Radiopharmaceutical for Staphylococcus Aureus Detection in Mouse Model
by: Akram Fazli, et al.
Published: (2012-03-01)

The disturbance of oxidant-antioxidant balance in rat colonic mucosa after antibiotic therapy
by: Y. Holota, et al.
Published: (2015-12-01)

Evaluation of the Clinical Use of Ceftriaxone among In-Patients in Selected Health Facilities in Uganda
by: Paul Kutyabami, et al.
Published: (2021-06-01)

Rare but not forgotten: A case of meningitis due to ceftriaxone-resistant Streptococcus pneumoniae
by: Naomi Hauser, et al.
Published: (2018-01-01)

Analysis of Patients with Central Nervous System Infection at Our Clinic: Five-year Results
by: Şafak Özer BALIN, et al.
Published: (2019-12-01)

Molecular Characterization of Multidrug Resistant Strains of Acinetobacter baumannii Isolated from Intensive Care Units in West of Iran
by: Parviz Mohajeri, et al.
Published: (2017-02-01)

Ceftriaxone-induced Agranulocytosis
by: Lénio Couto, et al.
Published: (2021-01-01)

Effect of different treatments on macrophage differentiation in chronic obstructive pulmonary disease and repeated pulmonary infection
by: Run Liu, et al.
Published: (2020-08-01)

Morphological effect of Ceftriaxone on Pseudomonas aeruginosa and Proteus mirabilis
by: Mahmoud Zakei Alhaso
Published: (2009-06-01)

Self Mutilating Behaviour in Severe Meningococcal Infection; An Interesting Association
by: Anju Dinkar, et al.
Published: (2016-05-01)